Letter.

Letter Published in The National UAE on 27May 20  Sensible to avert risk and suspend the trial of anti-malaria drug

With reference to the report Coronavirus: WHO suspends trials of hydroxychloroquine as treatment (May 26): the decision of the WHO chief Tedros Adhanom Ghebreyesus is a good and timely move. His decision came after a study suggested the drug could increase the risk of death among Covid-19 patients. Safety is important during this hour. Already the virus has taken too many lives, the toll in the US alone nearing 100,000. Even though US President Donald Trump had been taking it, if the drug is any threat to life, it is sensible to pause trials.

K Ragavan, Bengaluru, India